[1] Zhao AG, Li T, You SF, et al. Effects of Wei Chang An on expression of multiple genes in human gastric cancer grafted onto nude mice[J]. World J Gastroenterol, 2008,14(5):693-700. [2] Hanako Y, Kappei T, Yoshihide K, et al. Isolation of a mammalian homologue of a fission yeast differentiation regulator[J]. Mol Cell Bio, 1999,19(5): 3829-3841. [3] Brazão TF, Demmers J, van IJcken W, et al. A new function of ROD1 in nonsense-mediated mRNA decay[J]. FEBS Lett,2012,586(8):1101-1010. [4] Schmittgen TD, Zakrajsek BA, Mills AG, et al. Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods[J]. Anal Biochem,2000,285(2):194-204. [5] Paoletti X, Oba K, Burzykowski T, et al. Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis[J]. JAMA, 2010,303(17):1729-1737. [6] Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010[J]. CA Cancer J Clin, 2010,60:277-300. [7] Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J].Int J Cancer, 2010,127(12):2893-2917. [8] Jemal A, Bray F, Center MM, et al. Global cancer statistics[J].CA Cancer J Clin, 2011,61(2):69-90. [9] Spellman R, Llorian M, Smith CW. Crossregulation and Functional Redundancy between the Splicing Regulator PTB and Its Paralogs nPTB and ROD1[J]. Mol Cell,2007,27(3):420-434. [10] Maniatis T, Tasic B. Alternative pre-mRNA splicing and proteome expansion in metazoans[J]. Nature, 2002 ,418(6894):236-243. [11] Hagen RM, Ladomery MR. Role of splice variants in the metastatic progression of prostate cancer[J].Biochemical Society Transactions,2012,40(4):870-874. [12] Pal S, Gupta R, Davuluri RV. Alternative transcription and alternative splicing in cancer[J]. Pharmacol Ther, 2012,136(3): 283-294. [13] Kim YJ, Kim HS. Alternative Splicing and Its Impact as a Cancer Diagnostic Marker[J]. Genomics Inf, 2012,10(2): 74-80. [14] Gao G, Dou QP. G(1) phase-dependent expression of bcl-2 mRNA and protein correlates with chemoresistance of human cancer cells[J].Mol Pharmacol, 2000,58(5): 1001-1010. [15] Capuzzi D, Santoro E, Hauck WW, et al. Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival[J].Cancer, 2000,88(1): 24-34. [16] Levy DE, Darnell JE Jr. Stats: transcriptional control and biological impact[J].Nat Rev Mol Cell Biol, 2002,3(9): 651-662. [17] Gong W, Wang L, Yao JC, et al.Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer[J].Clin Cancer Res, 2005, 11(4): 1386-1393. |